Literature DB >> 18355873

Interaction between age and comorbidity as predictors of mortality after radical prostatectomy.

Michael Froehner1, Rainer Koch, Rainer J Litz, Oliver W Hakenberg, Sven Oehlschlaeger, Manfred P Wirth.   

Abstract

PURPOSE: We identified an age range in which comorbidity is most closely associated with premature mortality after radical prostatectomy.
MATERIALS AND METHODS: A total of 1,302 patients selected for radical prostatectomy were stratified according to the Charlson score, the American Society of Anesthesiologists physical status classification, the New York Heart Association classification of heart insufficiency and the classification of angina pectoris of the Canadian Cardiovascular Society. Furthermore, patients were subdivided into several age groups. Comorbid mortality and overall mortality were the study end points. The prognostic relevance of the comorbidity classifications was assessed by comparing Mantel-Haenszel HRs, p values and 10-year overall survival rates.
RESULTS: The discriminative capacity of all 4 investigated comorbidity classifications decreased when patients 70.0 years or older were included with decreasing HRs and increasing p values. Except for the American Society of Anesthesiologists classification HRs for comparing the high vs low risk groups tended to decrease and p values simultaneously tended to increase when patients younger than 63.0 years were included. In the age range of between 63.0 and 69.9 years 10-year overall survival rates differed by 14% to 28% between patients with a high vs low comorbid risk compared with 6% to 13% in the whole sample.
CONCLUSIONS: The discriminative capacity of the investigated comorbidity classifications was greatest in the age group that was 63.0 to 69.9 years old. In patients younger than 63.0 or older than 70.0 years comorbidity classification seemed to contribute little to the prediction of comorbid mortality.

Entities:  

Mesh:

Year:  2008        PMID: 18355873     DOI: 10.1016/j.juro.2008.01.023

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Prediction of mortality after radical prostatectomy by Charlson comorbidity index.

Authors:  Thomas J Guzzo; Paul Dluzniewski; Ryan Orosco; Elizabeth A Platz; Alan W Partin; Misop Han
Journal:  Urology       Date:  2010-09       Impact factor: 2.649

2.  The influence of comorbidities on overall survival among older women diagnosed with breast cancer.

Authors:  Jennifer L Patnaik; Tim Byers; Carolyn Diguiseppi; Thomas D Denberg; Dana Dabelea
Journal:  J Natl Cancer Inst       Date:  2011-06-30       Impact factor: 13.506

3.  [Social gradient of PSA screening? 8 years follow up from the cancer registry of the tumor center in Regensburg].

Authors:  T Klotz; M J Mathers; M Gerken; M Klinkhammer-Schalke; F Hofstädter
Journal:  Urologe A       Date:  2010-12       Impact factor: 0.639

4.  Patients with localised prostate cancer (t1 - t2) show improved overall long-term survival compared to the normal population.

Authors:  Michael J Mathers; Stephan Roth; Monika Klinkhammer-Schalke; Michael Gerken; Ferdinand Hofstaedter; Stefan Wilm; Theodor Klotz
Journal:  J Cancer       Date:  2011-02-08       Impact factor: 4.207

5.  Impact of the ASA Physical Status Score on Adjuvant Chemotherapy Eligibility and Survival of Upper Tract Urothelial Carcinoma Patients: a Multicenter Study.

Authors:  Ho Won Kang; Sung Pil Seo; Won Tae Kim; Yong June Kim; Seok Joong Yun; Sang Cheol Lee; Young Deuk Choi; Yun Sok Ha; Tae Hwan Kim; Tae Gyun Kwon; Seok Soo Byun; Seong Uk Jeh; Wun Jae Kim
Journal:  J Korean Med Sci       Date:  2017-02       Impact factor: 2.153

6.  Patient characteristics predicting prolonged length of hospital stay following robotic-assisted radical prostatectomy.

Authors:  Albert El Hajj; Muhieddine Labban; Guillaume Ploussard; Jabra Zarka; Nassib Abou Heidar; Aurelie Mailhac; Hani Tamim
Journal:  Ther Adv Urol       Date:  2022-03-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.